Roche to complete $1.5 billion acquisition of U.S. biopharma company Poseida

Roche to complete $1.5 billion acquisition of U.S. biopharma company Poseida

Submitted by admin on January 8, 2025 - 11:25am
Source: 
Pharma Live
News Tags: 
Roche
M&A
Poseida Therapeutics
blood cancer
Headline: 
Roche to complete $1.5 billion acquisition of U.S. biopharma company Poseida
snippet: 

Roche (ROG.S) on Wednesday said it planned to complete its purchase of U.S. biopharmaceutical company Poseida Therapeutics (PSTX.O), a specialist in complex immune cell therapies to treat several types of blood cancer.

Do Not Allow Advertisers to Use My Personal information